Article info
PDFPostScript
Correspondence
Tumour necrosis factor-α antagonism: a potential therapeutic target for prevention of arrhythmogenesis in the setting of acute myocardial infarction?
- Correspondence to British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4SU, UK; gareth.padfield{at}nhs.net
Citation
Tumour necrosis factor-α antagonism: a potential therapeutic target for prevention of arrhythmogenesis in the setting of acute myocardial infarction?
Publication history
- First published September 7, 2013.
Online issue publication
May 30, 2016
Article Versions
- Previous version (30 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions